section name header

Indications

REMS

Unlabeled Use:

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: ARRHYTHMIAS.

Endo: gynecomastia.

GI: constipation, diarrhea, nausea.

GU: sperm count, erectile dysfunction.

Hemat: AGRANULOCYTOSIS, APLASTIC ANEMIA, anemia, neutropenia, thrombocytopenia.

Local: pain at IM site.

Neuro: confusion, dizziness, drowsiness, hallucinations, headache.

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

see Calculator

Renal Impairment

  • PO (Adults): CCr 10–50 mL/min-administer normal dose every 24 hr or 50% dose at normal dosing intervalCCr <10 mL/min — 20 mg at bedtime; interval may need to be to every 36–48 hr.

US Brand Names

Pepcid, Pepcid AC

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: antiulcer agents

Pharmacologic Classification: histamine h2 antagonists

Pharmacokinetics

Absorption: 40–45% absorbed following oral administration.

Distribution: Enters breast milk and cerebrospinal fluid.

Protein Binding: 15–20%.

Metabolism/Excretion: Up to 70% excreted unchanged by the kidneys, 30–35% metabolized by the liver.

Half-life: Infants: 4.5–15 hr; Children: 3.3–5.7 hr; Adults: 2.5–3.5 hr.

Time/Action Profile

ROUTEONSETPEAKDURATION
POwithin 60 min1–4 hr6–12 hr
IVwithin 60 min0.5–3 hr8–15 hr

Patient/Family Teaching

Pronunciation

fa-MOE-ti-deen audio

Code

NDC Code*